Search

Search Constraints

You searched for: Author/Creator Sahoo, Debasis

Search Results

4. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study). Issue 10 (24th August 2020)

9. Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. Issue 1 (29th July 2021)